Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2015 09:00 ET | Source: Singulex, Inc.

US Patent Awarded to Singulex for Expanded Use of Biomarkers Troponin I and T to Detect Cardiac Health Status With Single-Molecule Methods

ALAMEDA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer of Single Molecule Counting technology for use in both medical practice diagnostics and scientific research, has...
November 05, 2015 09:00 ET | Source: Singulex, Inc.

Singulex Receives European Patent Expanding Use of Biomarkers Troponin I and T to Detect Cardiac Health Status With High-Sensitivity Methods

ALAMEDA, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer of Single Molecule Counting technology for use in both medical practice diagnostics and scientific research, has...
July 14, 2015 11:00 ET | Source: Singulex, Inc.

Singulex Demonstrates Ultrasensitive "Sgx Clarity(TM) System" at AACC 2015

– Single Molecule Counting technology at the heart of development of a new in vitro diagnostics system; Company plans to commercialize in 2016 – – Multiple presentations...
May 21, 2015 09:00 ET | Source: Singulex, Inc.

Singulex Announces EMD Millipore to Acquire Exclusive Rights to Singulex's Ultra-Sensitive Single Molecule Counting (SMC(TM)) Technology

- EMD Millipore to acquire exclusive worldwide rights to Singulex's SMCTM technology – instruments, assays and services – for research applications - - Combination of Singulex's...
April 30, 2015 10:00 ET | Source: Singulex, Inc.

Singulex Announces Partnership With The Dutch Technology Foundation (STW) to Accelerate the Development of Clinical Biomarkers

ALAMEDA, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today...
April 28, 2015 10:00 ET | Source: Singulex, Inc.

Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers

ALAMEDA, Calif., April 28, 2015 (GLOBE NEWSWIRE) -- Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today...
April 09, 2015 10:00 ET | Source: Singulex, Inc.

Singulex Announces Collaboration With CHDI Foundation to Develop Biomarker Assays for Huntington's Disease

– Earlier research using Singulex's Huntington's disease research immunoassay outlined in Journal of Clinical Investigation – – Assay measures build-up of a harmful mutant...